triazoles has been researched along with dolutegravir in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Fang, J; Jadhav, PR | 1 |
Lacombe, K; Surgers, L | 1 |
Bigoloni, A; Boeri, E; Castagna, A; Cavarelli, M; Galli, A; Mainetti, L; Nozza, S; Pignataro, AR; Sampaolo, M; Scarlatti, G; Tolazzi, M | 1 |
Barnett, C; Cuffe, R; Granier, C; Machida, M; Roger, J; Wang, C | 1 |
Anderson, MS; Butterton, JR; Fan, L; Hussaini, A; Khalilieh, S; Liu, R; Rizk, ML; Ross, LL; Shah, V; Song, I; Yee, KL | 1 |
Álvarez, H; Llibre, JM; Yzusqui, M | 1 |
Arribas, JR; Battegay, M; Béguelin, C; Bhagani, S; Cinque, P; Collins, S; Cotter, A; De Miguel, R; Guaraldi, G; Kirk, O; Kowalska, JD; Mallon, P; Marzolini, C; Molina, JM; Podlekareva, D; Rauch, A; Ryom, L; Winston, A | 1 |
Cattelan, AM; Leoni, D; Mazzitelli, M; Putaggio, C; Sasset, L | 1 |
2 review(s) available for triazoles and dolutegravir
Article | Year |
---|---|
Hepatoxicity of new antiretrovirals: a systematic review.
Topics: Anti-Retroviral Agents; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Cyclohexanes; Darunavir; Heterocyclic Compounds, 3-Ring; Humans; Maraviroc; Nitriles; Oxazines; Piperazines; Pyridazines; Pyridones; Pyrimidines; Pyrrolidinones; Quinolones; Raltegravir Potassium; Rilpivirine; Sulfonamides; Triazoles | 2013 |
Clinical Impact of Virological Failure and Resistance Analysis Definitions used in Pivotal Clinical Trials of Initial Antiretroviral Treatment: A Systematic Review
Topics: Amides; Anti-Retroviral Agents; Clinical Trials as Topic; Cobicistat; Darunavir; Drug Resistance, Viral; Genotype; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, 4 or More Rings; HIV Infections; Humans; Oxazines; Piperazines; Pyridones; Quinolones; Rilpivirine; RNA, Viral; Triazoles; Viral Load | 2018 |
3 trial(s) available for triazoles and dolutegravir
Article | Year |
---|---|
From in vitro EC₅₀ to in vivo dose-response for antiretrovirals using an HIV disease model. Part I: a framework.
Topics: Adenine; Anti-HIV Agents; Cyclohexanes; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV-1; Humans; Inhibitory Concentration 50; Male; Maraviroc; Models, Biological; Nitriles; Organophosphonates; Oxazines; Piperazines; Pyridazines; Pyridones; Pyrimidines; RNA, Viral; Tenofovir; Triazoles | 2012 |
Missing CD4+ cell response in randomized clinical trials of maraviroc and dolutegravir.
Topics: Adult; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cyclohexanes; Data Interpretation, Statistical; Datasets as Topic; Double-Blind Method; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; HIV-1; Humans; Male; Maraviroc; Models, Statistical; Oxazines; Piperazines; Pyridones; Triazoles; United States | 2015 |
A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir.
Topics: Adult; Area Under Curve; Drug Interactions; Drug Therapy, Combination; Fasting; Female; Heterocyclic Compounds, 3-Ring; HIV Integrase Inhibitors; Humans; Male; Oxazines; Piperazines; Pyridones; Reverse Transcriptase Inhibitors; Triazoles; Young Adult | 2017 |
3 other study(ies) available for triazoles and dolutegravir
Article | Year |
---|---|
Complexity and dynamics of HIV-1 chemokine receptor usage in a multidrug-resistant adolescent.
Topics: Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Chemokine CCL5; Cyclohexanes; Darunavir; Drug Resistance, Multiple, Viral; Heterocyclic Compounds, 3-Ring; HIV Envelope Protein gp120; HIV Reverse Transcriptase; HIV-1; Humans; Maraviroc; Oxazines; Peptide Fragments; Phylogeny; Piperazines; Pyridones; Receptors, CCR5; Receptors, CXCR4; Ritonavir; Sulfonamides; Triazoles; Viral Load; Viral Tropism | 2014 |
2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0.
Topics: Age Factors; Anti-Retroviral Agents; Comorbidity; Drug Interactions; Drug Therapy, Combination; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Lamivudine; Oxazines; Piperazines; Pyridones; Treatment Outcome; Triazoles | 2020 |
Real life use of dolutegravir doravirine dual regimen in experienced elderly PLWH with multiple comorbidities and on polypharmacy: A retrospective analysis.
Topics: Aged; Aged, 80 and over; Anti-HIV Agents; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Infant; Male; Middle Aged; Oxazines; Piperazines; Polypharmacy; Pyridones; Retrospective Studies; Treatment Outcome; Triazoles; Viral Load | 2021 |